We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Liberty Latin America Class C
LILAK
$1.5B
| $17.5M | 0.12% |
2,167,614
+1,473,742
| +212% | +$12.5M |
|
177
Genmab
GMAB
$17.7B
| $17.5M | 0.12% |
516,303
+279,003
| +118% | +$7.6M |
|
178
Lennar Class A
LEN
$20.4B
| $17.5M | 0.12% |
293,334
+253,300
| +633% | +$12.9M |
|
|
MLNX
179
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $17.4M | 0.12% |
139,267
-969,611
| -87% | -$118M |
|
180
Tractor Supply
TSCO
$16.3B
| $17.4M | 0.12% |
658,405
-57,140
| -8% | -$1.25M |
|
|
CBPO
181
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $17.2M | 0.12% |
+168,318
| New | +$18M |
|
182
Sturm, Ruger & Co
RGR
$610M
| $17M | 0.12% |
+223,943
| New | +$13.6M |
|
183
Amgen
AMGN
$203B
| $16.9M | 0.12% |
71,595
+66,642
| +1,345% | +$15.2M |
|
184
Equitable Holdings
EQH
$13.1B
| $16.9M | 0.12% |
875,299
+874,259
| +84,063% | +$15.6M |
|
185
Knowles
KN
$3.22B
| $16.7M | 0.12% |
1,097,124
+1,018,880
| +1,302% | +$15.2M |
|
|
LOGM
186
DELISTED
LogMein, Inc.
LOGM
| $16.7M | 0.12% |
197,471
+178,280
| +929% | +$15.1M |
|
|
BKI
187
DELISTED
Black Knight, Inc. Common Stock
BKI
| $16.4M | 0.12% |
+226,622
| New | +$16.1M |
|
188
Stellantis
STLA
$16.5B
| $16.3M | 0.11% |
1,625,111
+828,411
| +104% | +$7.16M |
|
|
ADSW
189
DELISTED
Advanced Disposal Services Inc
ADSW
| $16.3M | 0.11% |
539,429
+296,305
| +122% | +$9.46M |
|
190
MSCI
MSCI
$40B
| $16.1M | 0.11% |
48,346
-55,544
| -53% | -$18M |
|
|
WMGI
191
DELISTED
Wright Medical Group Inc
WMGI
| $16.1M | 0.11% |
543,022
+139,399
| +35% | +$4.08M |
|
192
Salesforce
CRM
$134B
| $16M | 0.11% |
85,253
+63,000
| +283% | +$10.6M |
|
|
INFO
193
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $16M | 0.11% |
211,303
-34,954
| -14% | -$2.38M |
|
194
Charles River Laboratories
CRL
$10.9B
| $15.9M | 0.11% |
+91,448
| New | +$14.6M |
|
195
McCormick & Company Non-Voting
MKC
$13.4B
| $15.9M | 0.11% |
177,360
+146,428
| +473% | +$12.1M |
|
196
CVS Health
CVS
$137B
| $15.8M | 0.11% |
243,274
-651,918
| -73% | -$41.1M |
|
197
Tyson Foods
TSN
$20.2B
| $15.8M | 0.11% |
264,505
+201,284
| +318% | +$12.2M |
|
|
BNY
198
Bank of New York Mellon
BNY
$108B
| $15.7M | 0.11% |
406,623
+404,431
| +18,450% | +$14.8M |
|
199
BJs Wholesale Club
BJ
$11.9B
| $15.7M | 0.11% |
420,288
-14,269
| -3% | -$438K |
|
200
Federated Hermes
FHI
$4.4B
| $15.6M | 0.11% |
658,915
-123,732
| -16% | -$2.74M |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.